Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis

Inflammatory Bowel Diseases

Volumn 16, Issue 6, 2010, Pages 999-1007

  Bjerrum, Jacob Tveiten ^a   Hansen, Morten ^b   Olsen, Jørgen ^b   Nielsen, Ole Haagen ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Colonocytes; Continuous inflammation; Gene expression profiles; Mucosal colonic biopsies

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; MESALAZINE;

ADULT; ARTICLE; CELL TYPE; CLINICAL ARTICLE; COLON; COLON BIOPSY; COLONOCYTE; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LAMINA PROPRIA; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; CHEMOKINES; COLITIS, ULCERATIVE; DENMARK; FEMALE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTESTINAL MUCOSA; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77952697077     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21142     Document Type: Article

References (33)

1. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117:514-521. (Pubitemid 46348505)
2. Wu F, Dassopoulos T, Cope L, et al. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis. 2007;13:807-821. (Pubitemid 47203859)
3. Olsen J, Gerds TA, Seidelin JB, et al. Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genomewide gene expression data. Inflamm Bowel Dis. 2009;15:1032-1038.
4. Bezabeh T, Somorjai RL, Smith IC, et al. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease. Am J Gastroenterol. 2001;96: 442-448.
5. Bjerrum JT, Nielsen OH, Wang YL, et al. Technology insight: metabonomics in gastroenterology-basic principles and potential clinical applications. Nat Clin Pract Gastroenterol Hepatol. 2008;5:332-343. (Pubitemid 351803604)
6. Spiller R. Clinical update: irritable bowel syndrome. Lancet. 2007; 369:1586-1588. (Pubitemid 46710110)
7. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670-1689.
8. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629.
9. Bentley E, Jenkins D, Campbell F, et al. How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop. J Clin Pathol. 2002;55:955-960. (Pubitemid 35454501)
10. Seidelin JB, Horn T, Nielsen OH. Simple and efficient method for isolation and cultivation of endoscopically obtained human colonocytes. Am J Physiol Gastrointest Liver Physiol. 2003;285:G1122-G1128.
11. Seidelin JB, Nielsen OH. Attenuated apoptosis response to Fas-ligand in active ulcerative colitis. Inflamm Bowel Dis. 2008;14:1623-1629.
12. Csillag C, Nielsen OH, Borup R, et al. Clinical phenotype and gene expression profile in Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2007;292:G298-G304. (Pubitemid 46091632)
13. Wang L, Lofton C, Popp M, et al. Using luminescent nanoparticles as staining probes for Affymetrix GeneChips. Bioconjug Chem. 2007;18: 610-613.
14. Csillag C, Nielsen OH, Vainer B, et al. Expression of the genes dual oxidase 2, lipocalin 2 and regenerating islet-derived 1 alpha in Crohn's disease. Scand J Gastroenterol. 2007;42:454-463.
15. Irizarry RA, Bolstad BM, Collin F, et al. Summaries of Affymetrix GeneChip probe level data. Nucl Acids Res. 2003;31:e15.
16. Gentleman R, Carey V, Bates D, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
17. Eriksson L, Andersson PL, Johansson E, et al. Megavariate analysis of environmental QSAR data. Part I: a basic framework founded on principal component analysis (PCA), partial least squares (PLS), and statistical molecular design (SMD). Mol Divers. 2006;10:169-186.
18. Pérez-Enciso M, Tenenhaus M. Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLSDA) approach. Hum Genet. 2003;112:581-592.
19. Eriksson L, Jaworska J, Worth AP, et al. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ Health Perspect. 2003; 111:1361-1375.
20. Harris MA, Clark J, Ireland A, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004;32:D258-D261.
21. Rivals I, Personnaz L, Taing L, et al. Enrichment or depletion of a GO category within a class of genes: which test? Bioinformatics. 2007;23:401-407.
22. von Stein P, Lofberg R, Kuznetsov NV, et al. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome. Gastroenterology. 2008;134:1869-1881.
23. Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol. 2001;69:331-339.
24. Weninger W, Carlsen HS, Goodarzi M, et al. Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol. 2003;170:4638-4648.
25. Zimmerman NP, Vongsa RA, Wendt MK, et al. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1000-1011.
26. Haringman JJ, Kraan MC, Smeets TJM, et al. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62:715-721.
27. Trebst C, Lykke Sorensen T, Kivisakk P, et al. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol. 2001;159:1701-1710.
28. Noble CL, Abbas AR, Cornelius J, et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut. 2008;57:1398-1405.
29. Festen EA, Goyette P, Scott R, et al. Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut. 2009;58:799-804.
30. Franke A, Balschun T, Karlsen TH, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008;40:713-715.
31. Eriksen KW, Sondergaard H, Woetmann A, et al. The combination of IL-21 and IFN-alpha boosts STAT3 activation, cytotoxicity and experimental tumor therapy. Mol Immunol. 2009;46:812-820.
32. Leonard WJ, Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol. 2005;5:688-698.
33. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol. 2002;14:129-135. (Pubitemid 34085117)